Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor
Clinical trial NCT06540937 · RECRUITING
Trial details
- NCT number
- NCT06540937
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2024-12-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.